Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
In recent years, several associations between common chronic human disorders and altered gut microbiome composition and function have been reported. In most of these reports, treatment regimens were not controlled for and conclusions could thus be confounded by the effects of various drugs on the microbiota, which may obscure microbial causes, protective factors or diagnostically relevant signals. Our study addresses disease and drug signatures in the human gut microbiome of type 2 diabetes mellitus (T2D). Two previous quantitative gut metagenomics studies of T2D patients that were unstratified for treatment yielded divergent conclusions regarding its associated gut microbial dysbiosis. Here we show, using 784 available human gut metagenomes, how antidiabetic medication confounds these results, and analyse in detail the effects of the most widely used antidiabetic drug metformin. We provide support for microbial mediation of the therapeutic effects of metformin through short-chain fatty acid production, as well as for potential microbiota-mediated mechanisms behind known intestinal adverse effects in the form of a relative increase in abundance of Escherichia species. Controlling for metformin treatment, we report a unified signature of gut microbiome shifts in T2D with a depletion of butyrate-producing taxa. These in turn cause functional microbiome shifts, in part alleviated by metformin-induced changes. Overall, the present study emphasizes the need to disentangle gut microbiota signatures of specific human diseases from those of medication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“patient treatment with the drug metformin, a variable that subjects had not been stratified for previously, constituted the main determinant of microbial signatures in diabetic cohorts [62].”
From Antibiotic-Induced Changes in the Intestinal Microbiota and Disease (2016) · cites this paper as [62]
In the citing paper
“This action is an important determinant for the anti-hyperglycemic therapeutic effects, the gastrointestinal side effects and possibly the anti-aging effects of metformin (88, 89).”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [88]
In the citing paper
“As for C. elegans, metformin use in humans will change the microbiome.”
From A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan (2021) · cites this paper as [88]
In the citing paper
“Studies comparing individuals with T2D treated or not with metformin identified a higher level of E. coli and a lower level of Intestinibacter in the metformin-treated individuals, while confirming reduced levels of butyrate-producing bacteria such as Roseburia spp., F. prausnitzii, and unnamed Clostridiales in the untreated individuals compared to healthy controls5, 6, 34, 35.”
From The gut microbiome in atherosclerotic cardiovascular disease (2017) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
The SILVA ribosomal RNA gene database project: improved data processing and web-based tools
Quast, C., Pruesse, E., Yilmaz, P., Gerken, J., Schweer, T., Yarza, P., Peplies, J., & Glöckner, F. O. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1219 · Cited by 33,055
Regularization Paths for Generalized Linear Models via Coordinate Descent
Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927
UPARSE: highly accurate OTU sequences from microbial amplicon reads
Edgar, R. C. (2013) · Nature Methods · doi:10.1038/nmeth.2604 · Cited by 16,707
FLASH: fast length adjustment of short reads to improve genome assemblies
Magoč, T., & Salzberg, S. L. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr507 · Cited by 15,366
UCHIME improves sensitivity and speed of chimera detection
Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., & Knight, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr381 · Cited by 15,114
ggplot2: Elegant Graphics for Data Analysis
Wickham, H. (2009) · doi:10.1007/978-0-387-98141-3 · Cited by 14,447
A new method for non-parametric multivariate analysis of variance
Anderson, M. J. (2001) · Austral Ecology · doi:10.1111/j.1442-9993.2001.01070.pp.x · Cited by 13,828
Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences
Li, W., & Godzik, A. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl158 · Cited by 11,410
VEGAN, a package of R functions for community ecology
Dixon, P. (2003) · Journal of Vegetation Science · doi:10.1111/j.1654-1103.2003.tb02228.x · Cited by 6,824
Cited by
Items 901–1,000 of 1,006
Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method
Petakh, P., Kobyliak, N. M., & Kamyshnyi, O. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1142578 · Cited by 36
Carr, R. M., Li, Y., Chau, L., Friedman, E. S., Lee, J., Adorini, L., Erickson, M., Zaru, L., Shringarpure, R., MacConell, L., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000474 · Cited by 36
Petakh, P., Kamyshna, I. I., Oksenych, V., Kainov, D. E., & Kamyshnyi, O. (2023) · Pharmaceuticals · doi:10.3390/ph16060904 · Cited by 36
Integration of polygenic and gut metagenomic risk prediction for common diseases
Liu, Y., Ritchie, S. C., Teo, S. M., Ruuskanen, M. O., Kambur, O., Zhu, Q., Sanders, J. G., Vázquez‐Baeza, Y., Verspoor, K. M., Jousilahti, P., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00590-7 · Cited by 35
Byndloss, M. X., Devkota, S., Duca, F. A., Niess, J. H., Nieuwdorp, M., Orho‐Melander, M., Sanz, Y., Tremaroli, V., & Zhao, L. (2024) · Diabetes · doi:10.2337/dbi24-0028 · Cited by 35
Qin, X., Chen, M., He, B., Chen, Y., & Zheng, Y. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1539972 · Cited by 35
Zhang, M., Wei, Z., Wei, B., Lai, C., Zong, G., Tao, E., Fan, M., Pan, Y., Zhou, B., Shen, L., et al. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.04.022 · Cited by 35
Henry, R. R., Frías, J. P., Walsh, B., Skare, S., Hemming, J., Burns, C. M., Bicsak, T. A., Baron, A., & Fineman, M. S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203946 · Cited by 35
Barengolts, E. I., Green, S. J., Chlipala, G. E., Layden, B. T., Eisenberg, Y., Priyadarshini, M., & Dugas, L. R. (2019) · Microorganisms · doi:10.3390/microorganisms7090320 · Cited by 35
Gut microbiome alterations and its link to corticosteroid resistance in immune thrombocytopenia
Wang, Y., Liu, F., Zhang, G., Su, Y. A., Sun, X., Chen, Q., Wang, C., Fu, H., He, Y., Zhu, X., et al. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1788-2 · Cited by 35
A critical assessment of gene catalogs for metagenomic analysis
Commichaux, S., Shah, N., Ghurye, J., Stoppel, A., Goodheart, J. A., Luque, G. G., Cummings, M. P., & Pop, M. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab216 · Cited by 35
Impact of non-antibiotic drugs on the human intestinal microbiome
Bastard, Q. L., Berthelot, L., Soulillou, J., & Montassier, E. (2021) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2021.1952075 · Cited by 35
Dwiyanto, J., Ayub, Q., Lee, S. M., Foo, S. C., Chong, C. W., & Rahman, S. (2021) · Microbial Genomics · doi:10.1099/mgen.0.000619 · Cited by 35
Kangwan, N., Pratchayasakul, W., Kongkaew, A., Pintha, K., Chattipakorn, N., & Chattipakorn, S. C. (2021) · Nutrients · doi:10.3390/nu13093141 · Cited by 35
Wanchaitanawong, W., Thinrungroj, N., Chattipakorn, S. C., Chattipakorn, N., & Shinlapawittayatorn, K. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109230 · Cited by 34
Huang, Y., Lou, X., Jiang, C., Ji, X., Tao, X., Sun, J., & Bao, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1044030 · Cited by 35
Bouillon, A., Ferreira, M. S. V., Awad, S. A., Richter, J., Hochhaus, A., Kunzmann, V., Dengler, J. B., Janssen, J. J. W. M., Ossenkoppele, G. J., Westerweel, P. E., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018017772 · Cited by 35
Metformin Biodistribution: A Key to Mechanisms of Action?
Sundelin, E. I. O., Jensen, J., Jakobsen, S., Gormsen, L. C., & Jessen, N. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa332 · Cited by 35
Williams, L. M., & Cao, S. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108605 · Cited by 35
The potential role of bacteria in pancreatic cancer: a systematic review
Li, P., Shu, Y., & Gu, Y. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa013 · Cited by 34
Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
Rebelo, R., Polónia, B. R. G., Santos, L. L., Vasconcelos, M. H., & Xavier, C. P. R. (2021) · Pharmaceuticals · doi:10.3390/ph14030280 · Cited by 34
Microbiota and viral hepatitis: State of the art of a complex matter
Milošević, I., Russo, E., Vujović, A., Barac, A. M., Stevanović, O., Gitto, S., & Amedei, A. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i33.5488 · Cited by 34
Molina‐Vega, M., César, M. J. P., Gutiérrez‐Repiso, C., Fernández‐Valero, A., Lima-Rubio, F., González‐Romero, S., Moreno‐Indias, I., & Tinahones, F. J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112465 · Cited by 34
Age-related diseases, therapies and gut microbiome: A new frontier for healthy aging
Barone, M., D’Amico, F., Rampelli, S., Brigidi, P., & Turroni, S. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111711 · Cited by 35
Metformin: update on mechanisms of action on liver diseases
Ruan, G., Wu, F., Shi, D., Sun, H., Wang, F., & Xu, C. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1327814 · Cited by 34
Potential effects of the most prescribed drugs on the microbiota-gut-brain-axis: A review
Garg, K., & Mohajeri, M. H. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.110883 · Cited by 34
Of mice and men: Is there a future for metformin in the treatment of hepatic steatosis?
Green, C., Marjot, T., Tomlinson, J., & Hodson, L. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13592 · Cited by 34
Cuyàs, E., Fernández‐Arroyo, S., Buxó, M., Pernas, S., Dorca, J., Álvarez, I., Torres‐Martínez, S., Pérez-García, J. M., Batista-López, N., Rodríguez‐Sánchez, C. A., et al. (2019) · Aging · doi:10.18632/aging.101960 · Cited by 34
Shan, K., Qu, H., Zhou, K., Wang, L., Zhu, C., Chen, H., Gu, Z., Cui, J., Fu, G., Li, J., et al. (2019) · mSystems · doi:10.1128/msystems.00219-19 · Cited by 34
Self-citationHan, Y., Kwon, E., & Choi, M. (2020) · Nutrients · doi:10.3390/nu12072113 · Cited by 34
Salomäki-Myftari, H., Vähätalo, L. H., Ailanen, L., Pietilä, S., Laiho, A., Hänninen, A., Pursiheimo, J.-P., Munukka, E., Rintala, A., Savontaus, E., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0163805 · Cited by 33
Human Gut Microbiota in Cardiovascular Disease
Ronen, D., Rokach, Y., Abedat, S., Qadan, A., Daana, S., Amir, O., & Asleh, R. (2024) · Comprehensive physiology · doi:10.1002/cphy.c230012 · Cited by 33
Anwardeen, N. R., Naja, K., & Elrayess, M. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1506767 · Cited by 33
Comparative Fingerprinting of the Human Microbiota in Diabetes and Cardiovascular Disease
Vamanu, E., Pelinescu, D. R., & Sârbu, I. (2016) · Journal of Medicinal Food · doi:10.1089/jmf.2016.0085 · Cited by 33
Cavallari, J. F., & Schertzer, J. D. (2017) · Journal of Obesity & Metabolic Syndrome · doi:10.7570/jomes.2017.26.3.161 · Cited by 33
Mitochondrial targets of metformin—Are they physiologically relevant?
Pecinová, A., Brázdová, A., Drahota, Z., Houštěk, J., & Mráček, T. (2019) · BioFactors · doi:10.1002/biof.1548 · Cited by 33
Ma, L., Hu, L., Jin, L., Wang, J., Li, X., Wang, W., Chang, S., Zhang, C., Wang, J., & Wang, S. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001255 · Cited by 33
Self-citationModulating the Gut Microbiota of Humans by Dietary Intervention with Plant Glycans
Tannock, G. W. (2020) · Applied and Environmental Microbiology · doi:10.1128/aem.02757-20 · Cited by 33
Modulation of the gut microbiota-adipose tissue-muscle interactions by prebiotics
Rodriguez, J., & Delzenne, N. M. (2021) · Journal of Endocrinology · doi:10.1530/joe-20-0499 · Cited by 33
Hou, K., Zhang, S., Wu, Z., Zhu, D., Chen, F., Lei, Z.-N., Liu, W., Xiao, C., & Chen, Z.-S. (2022) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2021.6323 · Cited by 35
Genetically Predicted Causality of 28 Gut Microbiome Families and Type 2 Diabetes Mellitus Risk
Xiang, K., Zhang, J., Xu, Y., Zhong, X., Ni, J., & Pan, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.780133 · Cited by 33
Translating Microbiome Research From and To the Clinic
Zhang, Z. J., Lehmann, C. J., Cole, C. G., & Pamer, E. G. (2022) · Annual Review of Microbiology · doi:10.1146/annurev-micro-041020-022206 · Cited by 33
The Influence of Gut Microbial Species on Diabetes Mellitus
AL-Ishaq, R. K., Samuel, S. M., & Büsselberg, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098118 · Cited by 33
Wang, F., Liu, X., Huang, F., Zhou, Y., Wang, X., Song, Z., Wang, S., Wang, X., Shi, D., Ruan, G., et al. (2024) · eLife · doi:10.7554/elife.89045.4 · Cited by 33
Pötgens, S. A., Lecop, S., Havelange, V., Li, F., Neyrinck, A. M., Neveux, N., Maertens, J. A., Walter, J., Schoemans, H. M., Delzenne, N. M., et al. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.09.021 · Cited by 33
Human gut microbiome: Therapeutic opportunities for metabolic syndrome—Hype or hope?
Horvath, A., Žukauskaitė, K., Hazia, O., Balázs, I., & Stadlbauer, V. (2023) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.436 · Cited by 33
The microbial-mammalian metabolic axis: a critical symbiotic relationship
Chilloux, J., Neves, A. L., Boulangé, C. L., & Dumas, M. (2016) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000284 · Cited by 33
Phenotypic Screening in C. elegans as a Tool for the Discovery of New Geroprotective Drugs
Bulterijs, S., & Braeckman, B. P. (2020) · Pharmaceuticals · doi:10.3390/ph13080164 · Cited by 33
The clinical application of metformin in children and adolescents: A short update.
Soliman, A., Sanctis, V. D., Alaaraj, N., & Hamed, N. (2020) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v91i3.10127 · Cited by 33
Microbiome–host systems interactions: Protective effects of propionate upon the blood–brain barrier
Hoyles, L., Snelling, T., Umlai, U.-K., Nicholson, J. K., Carding, S. R., Glen, R. C., & McArthur, S. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/170548 · Cited by 31
Rithi, A. T., Mitra, A., Banerjee, A., Ilanchoorian, D., Marotta, F., & Radhakrishnan, A. (2024) · Functional Food Science · doi:10.31989/ffs.v4i1.1271 · Cited by 32
Glaros, S. B., Mishra, S. P., Jain, S., Davis, F., Gabel, S. A., Mueller, G. A., Jarmusch, A. K., Mabundo, L. S., Courville, A. B., Walter, M. F., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2558071 · Cited by 32
Role of the microbiome in the normal and aberrant glycemic response
Suez, J., Shapiro, H., & Elinav, E. (2016) · Clinical Nutrition Experimental · doi:10.1016/j.yclnex.2016.01.001 · Cited by 34
Koch, C. A., Krabbe, S., & Hehmke, B. (2018) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-018-9478-8 · Cited by 32
Method development for cross-study microbiome data mining: Challenges and opportunities
Su, X., Jing, G., Zhang, Y., & Wu, S. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.07.020 · Cited by 32
Rosener, B., Sayin, S., Oluoch, P. O., García-González, A. P., Mori, H., Walhout, A. J. M., & Mitchell, A. (2020) · eLife · doi:10.7554/elife.59831 · Cited by 32
Metformin as a Treatment Strategy for Sjögren’s Syndrome
Kim, J., Kim, Y.-S., & Park, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137231 · Cited by 32
Su, C., Li, X., Yang, Y., Du, Y., Zhang, X., Wang, L., & Hong, B. (2021) · Nutrition and Diabetes · doi:10.1038/s41387-021-00169-w · Cited by 32
Ďásková, N., Módos, I., Krbcová, M., Kuzma, M., Pelantová, H., Hradecký, J., Heczková, M., Brátová, M., Videňská, P., Šplíchalová, P., et al. (2023) · Nutrition and Diabetes · doi:10.1038/s41387-023-00235-5 · Cited by 32
Papadakos, S. P., Ferraro, D., Carbone, G., Frampton, A. E., Vennarecci, G., Kykalos, S., Schizas, D., Theocharis, S. E., & Machairas, N. (2023) · Cancers · doi:10.3390/cancers15123161 · Cited by 32
Stagi, S., Ricci, F., Bianconi, M., Sammarco, M., Municchi, G., Toni, S., Lenzi, L., Verrotti, A., & de Martino, M. (2017) · Nutrients · doi:10.3390/nu9050524 · Cited by 32
GUT Microbiome-GUT Dysbiosis-Arterial Hypertension: New Horizons
Katsi, V. K., Didagelos, M., Skevofilax, S., Armenis, I., Kartalis, A. N., Vlachopoulos, C. V., Karvounis, H. I., & Tousoulis, D. M. (2018) · Current Hypertension Reviews · doi:10.2174/1573402114666180613080439 · Cited by 32
Metformin transporter pharmacogenomics: insights into drug disposition—where are we now?
Chan, P., Shao, L., Tomlinson, B., Zhang, Y., & Liu, Z.-M. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1541981 · Cited by 32
Antidiabetic drug treatment confounds gut dysbiosis associated with type 2 diabetes mellitus
Holmes, D. I. R. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.222 · Cited by 31
Luo, C., Wang, X., Huang, H., Mao, X., Zhou, H., & Liu, Z. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00371 · Cited by 31
Rapid LA-REIMS and comprehensive UHPLC-HRMS for metabolic phenotyping of feces
Meulebroek, L. V., Cameron, S. J. S., Plekhova, V., Spiegeleer, M. D., Wijnant, K., Michels, N., Henauw, S. D., Lapauw, B., Takáts, Z., & Vanhaecke, L. (2020) · Talanta · doi:10.1016/j.talanta.2020.121043 · Cited by 31
Wei, S., Brejnrod, A., Trivedi, U., Mortensen, M. S., Johansen, M. Y., Karstoft, K., Vaag, A. A., Ried‐Larsen, M., & Sørensen, S. J. (2021) · Gut Microbes · doi:10.1080/19490976.2021.2005407 · Cited by 31
Wang, X., Wang, Z., Liu, D., Jiang, H., Cai, C., Li, G., & Yu, G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.839640 · Cited by 31
Snapshot into the Type-2-Diabetes-Associated Microbiome of a Romanian Cohort
Pîrcălăbioru, G. G., Chifiriuc, M. C., Picu, A. A., Petcu, L. M., Trandafir, M.-F., & Savu, O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315023 · Cited by 31
Zubiaga, L., Briand, O., Auger, F., Touche, V., Hübert, T., Thévenet, J., Marciniak, C., Quenon, A., Bonner, C., Peschard, S., et al. (2019) · iScience · doi:10.1016/j.isci.2023.106057 · Cited by 31
Microbiota: A potential orchestrator of antidiabetic therapy
Liu, B., Zhang, L., Yang, H., Zheng, H., & Liao, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.973624 · Cited by 31
Karim, M. R., Iqbal, S., Mohammad, S., Lee, J. H., Jung, D.-H., Mathiyalagan, R., Yang, D., Yang, D. U., & Kang, S. C. (2023) · Microbiological Research · doi:10.1016/j.micres.2023.127346 · Cited by 31
Lin, K., Dong, C., Zhao, B., Zhou, B., & Li, Y. (2023) · MedComm · doi:10.1002/mco2.416 · Cited by 31
Liddicoat, C., Waycott, M., & Weinstein, P. (2016) · BioScience · doi:10.1093/biosci/biw127 · Cited by 31
Adherence to metformin and the onset of rheumatoid arthritis: a population-based cohort study
Naffaa, M. E., Rosenberg, V., Watad, ., Tiosano, S., Yavne, Y., Chodick, G., Amital, H., & Shalev, V. (2020) · Scandinavian Journal of Rheumatology · doi:10.1080/03009742.2019.1695928 · Cited by 31
Yamamoto, Y., Nakanishi, Y., Murakami, S., Aw, W., Tsukimi, T., Nozu, R., Ueno, M., Hioki, K., Nakahigashi, K., Hirayama, A., et al. (2018) · Microorganisms · doi:10.3390/microorganisms6040101 · Cited by 30
A hidden confounder for microbiome studies: medications used years before sample collection
Aasmets, O., Taba, N., Krigul, K. L., Andreson, R., Estonian Biobank Research Team, Org, E., Metspalu, M., Metspalu, A., Milani, L., & Esko, T. (2025) · mSystems · doi:10.1128/msystems.00541-25 · Cited by 30
Use Cases and Future Aspects of Intelligent Techniques in Microbial Data Analysis
Naveed, M., Memon, Z.-N., Abdullah, M., Makhdoom, S. I., Azeem, A., Mehmood, S., Salahuddin, M., Rajpoot, Z., & Majeed, M. (2024) · Microorganisms for sustainability · doi:10.1007/978-981-99-9621-6_17 · Cited by 31
Metformin-Associated Gastrointestinal Adverse Events Are Reduced by Probiotics: A Meta-Analysis
Szymczak-Pajor, I., Drzewoski, J., Wenclewska, S., & Śliwińska, A. (2024) · Pharmaceuticals · doi:10.3390/ph17070898 · Cited by 30
Chlorpyrifos modulates the mouse gut microbiota and metabolic activity
Nichols, R. G., Rimal, B., Hao, F., Peters, J. M., Davenport, E., & Patterson, A. D. (2024) · Environment International · doi:10.1016/j.envint.2024.109022 · Cited by 30
Maniar, K., Singh, V., Moideen, A., Bhattacharyya, R., Chakrabarti, A., & Banerjee, D. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.021 · Cited by 30
Impact of occupational exposure on human microbiota
Lai, P. S., & Christiani, D. C. (2018) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000502 · Cited by 31
Ding, Q., Tian, J., Li, M., Lian, F., Zhao, L., Wei, X., Han, L., Zheng, Y., Gao, Z., Yang, H., et al. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.530160 · Cited by 31
Chakaroun, R., Massier, L., Heintz‐Buschart, A., Said, N., Fallmann, J., Crane, A., Schütz, T., Dietrich, A., Blüher, M., Stümvoll, M., et al. (2021) · Genome Medicine · doi:10.1186/s13073-021-00919-6 · Cited by 31
Anti-diabetic effect of aloin via JNK-IRS1/PI3K pathways and regulation of gut microbiota
Zhong, R., Chen, L., Liu, Y., Xie, S., Li, S., Liu, B., & Zhao, C. (2021) · Food Science and Human Wellness · doi:10.1016/j.fshw.2021.07.019 · Cited by 30
Liu, H., Zhang, Z., Li, J., Liu, W., Warda, M., Cui, B., & El‐Aty, A. M. A. (2022) · Food & Function · doi:10.1039/d1fo02667d · Cited by 30
Self-citationSaleem, A., Ikram, A., Dikareva, E., Lahtinen, E., Matharu, D., Pajari, A., de Vos, W. M., Hasan, F., Salonen, A., & Jian, C. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2142009 · Cited by 31
Dysbiosis of gut microbiome contributes to glaucoma pathogenesis
Chen, S., Wang, Y., Liu, Y., Li, F., Chen, Y., Fang, X., Wen, T., Xu, S., Kermany, D., Deng, S., et al. (2022) · MedComm – Future Medicine · doi:10.1002/mef2.28 · Cited by 31
Misera, A., Łoniewski, I., Palma, J., Kulaszyńska, M., Czarnecka, W., Kaczmarczyk, M., Liśkiewicz, P., Samochowiec, J., & Skonieczna‐Żydecka, K. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1125022 · Cited by 30
Obesity is the main driver of altered gut microbiome functions in the metabolically unhealthy
de la Cuesta‐Zuluaga, J., Huus, K. E., Youngblut, N. D., Escobar, J. S., & Ley, R. E. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2246634 · Cited by 31
Wang, Y., Shao, S., Guo, C., Zhang, S., Li, M., & Ding, K. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.05.009 · Cited by 30
Goallec, A. L., Tierney, B. T., Luber, J. M., Cofer, E. M., Kostic, A. D., & Patel, C. J. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007895 · Cited by 31
Hou, D., Zhao, Q., Yousaf, L., Chen, B., Xue, Y., & Shen, Q. (2020) · Food & Function · doi:10.1039/d0fo00379d · Cited by 30
Mojsak, P., Rey-Stolle, F., Parfieniuk, E., Kretowski, A. J., & Ciborowski, M. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113617 · Cited by 30
Does Gut-Microbiome Interaction Protect against Obesity and Obesity-Associated Metabolic Disorders?
Zawada, A. E., Rychter, A. M., Ratajczak, A. E., Lisiecka-Masian, A., Dobrowolska, A., & Krela‐Kaźmierczak, I. (2020) · Microorganisms · doi:10.3390/microorganisms9010018 · Cited by 30
The microbiome and systemic sclerosis: A review of current evidence
Tan, T. C., Noviani, M., Leung, Y. Y., & Low, A. H. L. (2021) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2021.101687 · Cited by 30
The Dutch Microbiome Project defines factors that shape the healthy gut microbiomePreprint
Gaćeša, R., Kurilshikov, A., Vila, A. V., Sinha, T., Klaassen, M. A. Y., Bolte, L. A., Andreu‐Sánchez, S., Chen, L., Collij, V., Hu, S., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.27.401125 · Cited by 30
Farup, P. G., Lydersen, S., & Valeur, J. (2019) · Journal of Obesity · doi:10.1155/2019/4608315 · Cited by 29
Wang, M., Yang, F., Yan, X., Chao, X., Zhang, W., Yuan, C., & Zeng, Q. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14275 · Cited by 29
Ma, Y., Nenkov, M., Chen, Y., & Gaßler, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158352 · Cited by 28
“Microbes, including Oscillbacter, Clostridiaceae, and Erysipelotrichaceae, were significantly differentially abundant in obese individuals compared to non-obese [205–207].”
Background
Metadata
- Authors
- MetaHIT consortium, Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., Prifti, E., Vieira-Silva, S., Gudmundsdottir, V., Krogh Pedersen, H., Arumugam, M., Kristiansen, K., Yvonne Voigt, A., Vestergaard, H., Hercog, R., Igor Costea, P., Roat Kultima, J., Li, J., Jørgensen, T., Levenez, F., Dore, J., Bjørn Nielsen, H., Brunak, S., Raes, J., Hansen, T., Wang, J., Dusko Ehrlich, S., Bork, P., & Pedersen, O.
- Affiliations
- Vrije Universiteit Brussel (BE)
- University of Copenhagen (DK)
- Rega Institute for Medical Research (BE)
- European Molecular Biology Laboratory (DE)
- Microbiologie de l’alimentation au service de la santé (FR)
- BGI Group (China) (CN)
- Corresponding author
- Pedersen, Oluf
- ORCID
- Venue
- Nature
- Published
- 2015-12-02
- Volume
- 528
- Issue
- 7581
- Pages
- 262-266
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4681099
- OpenAlex
- W2188930066
- Cited by
- 2,116
- References
- 49
- Citations by year
- 2026: 113 · 2025: 167 · 2024: 212 · 2023: 194 · 2022: 253 · 2021: 270 · 2020: 256 · 2019: 185 · 2018: 197 · 2017: 150 · 2016: 112 · 2015: 3
- FWCI
- 66.83
- Type
- journal article
- Language
- en
- Update notices
- erratum (2017-05-04)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- HAL (submittedVersion, cc-by-nc-nd)
- HAL (submittedVersion)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- VBN Forskningsportal (Aalborg Universitet) (submittedVersion)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Funders
- Innovationsfonden
- European Molecular Biology Laboratory
- European Commission (600375, 2007–2013, FP7 2007-2013, HORIZON2020, FP7/2007, 305312, 201052, 261376)
- Agence Nationale de la Recherche (ANR-11-DPBS-0001)
- Lundbeckfonden
- Novo Nordisk
- Göteborgs Universitet
- Copenhagen Graduate School for Nanoscience and Nanotechnology
- Novo Nordisk Foundation Center for Basic Metabolic Research
- H. Lundbeck A/S
- FP7 Ideas: European Research Council (268985)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- type 2 diabetes, gut microbiota, metformin, antidiabetic drugs, dysbiosis, confounding by treatment, short-chain fatty acids, butyrate, Escherichia, metagenome-wide association study
- MeSH terms
- Gastrointestinal Microbiome, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Male, Metformin, RNA, Ribosomal, 16S, Biodiversity, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.